Use of S-10 hydroxy-10, 11-dihydro-carbamazepine for the treatment of anxiety and bipolar disorders

Details for Australian Patent Application No. 2007251901 (hide)

Owner Novartis AG

Inventors Gentsch, Conrad; Bilbe, Graeme; Vassout, Annick; Cryan, John F; Schmutz, Markus; McAllister, Kevin Hall

Agent Davies Collison Cave

Pub. Number AU-A-2007251901

Parent 2004212328

Filing date 20 December 2007

Wipo publication date 24 January 2008

International Classifications

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/22 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

Event Publications

17 January 2008 Complete Application Filed

24 January 2008 Application Open to Public Inspection

  Published as AU-A-2007251901

6 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007251902-Method and machine for stuffing natural casings with sausage emulsion

2007251900-Synergistic composition for modulating activity of substrate analogs for NAD+, NADP+, NADH+ or NADPH dependent enzymes and process thereof